multi-epitope melanoma peptide vaccine
Sponsors
Eastern Cooperative Oncology Group, University of Southern California, Craig L Slingluff, Jr, University of Virginia
Conditions
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension MelanomaIntraocular MelanomaIris MelanomaMalignant Conjunctival NeoplasmMelanoma (Skin)Metastatic Intraocular Melanoma
Phase 1
Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
CompletedNCT00118313
Start: 2004-11-04End: 2006-07-28Updated: 2020-03-27
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
CompletedNCT00118274
Start: 2005-03-31End: 2010-02-28Updated: 2021-04-20
Vaccine Therapy in Treating Patients With Advanced Melanoma
CompletedNCT00705640
Start: 2008-05-31Updated: 2016-12-16
Phase 2
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
CompletedNCT00071981
Start: 2005-05-09End: 2014-01-31Updated: 2023-06-28
Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma
CompletedNCT00085189
Start: 2004-05-31End: 2007-09-30Updated: 2014-05-22
Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
CompletedNCT00089193
Start: 2003-09-30Updated: 2014-12-23
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
CompletedNCT00089206
Start: 2002-08-31Updated: 2014-12-19